OK Biotech Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 13, 2023 at 09:38 am EST
Share
OK Biotech Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was TWD 275.7 million compared to TWD 308.37 million a year ago. Net income was TWD 0.832 million compared to TWD 46.34 million a year ago. Basic earnings per share from continuing operations was TWD 0.01 compared to TWD 0.44 a year ago. Diluted earnings per share from continuing operations was TWD 0.01 compared to TWD 0.39 a year ago.
For the nine months, sales was TWD 916.12 million compared to TWD 1,161.39 million a year ago. Net income was TWD 33.93 million compared to TWD 148.82 million a year ago. Basic earnings per share from continuing operations was TWD 0.27 compared to TWD 1.42 a year ago. Diluted earnings per share from continuing operations was TWD 0.27 compared to TWD 1.21 a year ago.
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
OK BIOTECH CO., LTD. 
